“…They reduce colonisation of the human vessels by circulating meningococci and prevent subsequent vascular dysfunctions, intravascular coagulation, and overwhelming inflammation, the hallmarks of invasive meningococcal infections. Finally, in consistence with the role of the vascular niche in promoting sustained bacteraemia leading to mice lethality (Capel et al, ), these compounds reduce bacteraemia and increase mice survival. In association with antibiotics, they reduce vascular inflammatory and thrombotic responses that were shown to be highly detrimental and correlated with the severity of the disease in patients (Girardin, Grau, Dayer, Roux‐Lombard, & Lambert, ; van Deuren et al, ; Waage, Brandtzaeg, Halstensen, Kierulf, & Espevik, ).…”